Solid Biosciences Inc. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Solid Biosciences Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2024.
  • Solid Biosciences Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $3.82M, a 97.2% increase year-over-year.
  • Solid Biosciences Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $10.5M, a 38% increase year-over-year.
  • Solid Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2024 was $10.5M, a 38% increase from 2023.
  • Solid Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.63M, a 1.17% increase from 2022.
  • Solid Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.54M, a 43.6% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $10.5M +$2.89M +38% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 $7.63M +$88K +1.17% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 $7.54M -$5.84M -43.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $13.4M +$1.74M +15% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-13
2020 $11.6M -$2.58M -18.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $14.2M +$8.25M +139% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
2018 $5.96M +$625K +11.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 $5.33M +$3.86M +263% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $1.47M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.